Most lately, it's been determined that conolidine and the above mentioned derivatives act to the atypical chemokine receptor three (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds into a big selection of endogenous opioids. Unlike most opioid receptors, this receptor acts as being a scavenger and will not activate a